Florida Post Acute Medical Services 1 Pa | |
2730 W Wilder Ave Tampa FL 33614-6809 | |
(813) 766-4018 | |
Not Available |
Full Name | Florida Post Acute Medical Services 1 Pa |
---|---|
Speciality | Hospitalist |
Location | 2730 W Wilder Ave, Tampa, Florida |
Authorized Official Name and Position | Michael Corvini (PRESIDENT) |
Authorized Official Contact | 8656931000 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Florida Post Acute Medical Services 1 Pa 1643 Nw 136th Avenue Building H, Suite 100 Sunrise FL 33323-3157 Ph: (865) 693-1000 | Florida Post Acute Medical Services 1 Pa 2730 W Wilder Ave Tampa FL 33614-6809 Ph: (813) 766-4018 |
NPI Number | 1255862439 |
---|---|
Provider Enumeration Date | 03/21/2017 |
Last Update Date | 04/27/2023 |
Certification Date | 04/27/2023 |
Medicare PECOS PAC ID | 2567729395 |
---|---|
Medicare Enrollment ID | O20171201002143 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1255862439 | NPI | - | NPPES |
Provider Name | Henry Elias Paez |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1093790313 PECOS PAC ID: 2062316151 Enrollment ID: I20031120000794 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lorraine Collins-fox |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1639594096 PECOS PAC ID: 7719870534 Enrollment ID: I20040205000590 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Clinton Jules |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1811923352 PECOS PAC ID: 8820983513 Enrollment ID: I20040220000546 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kathyrn M Kater |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1386657872 PECOS PAC ID: 1850287640 Enrollment ID: I20040227000122 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Annabelle M Matias |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1194709725 PECOS PAC ID: 0648160754 Enrollment ID: I20040319000962 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Ananthy Nallapillai |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1023198009 PECOS PAC ID: 9830183714 Enrollment ID: I20040413001068 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Fred J Rahaim |
---|---|
Provider Type | Practitioner - Psychologist Billing Independently |
Provider Identifiers | NPI Number: 1265475412 PECOS PAC ID: 8921092651 Enrollment ID: I20040414000422 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | David Conrad Siebert |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1780647057 PECOS PAC ID: 3678561966 Enrollment ID: I20040505000180 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Pradeep Arora |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1366466476 PECOS PAC ID: 6103816699 Enrollment ID: I20040518000602 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Frank Michael Alea |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1932153525 PECOS PAC ID: 6002806320 Enrollment ID: I20040526001402 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Adam T Aroyo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336137843 PECOS PAC ID: 6709867195 Enrollment ID: I20040601000660 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Susan Gross |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1932116266 PECOS PAC ID: 1052395399 Enrollment ID: I20040615001063 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Manuel A Lopez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1023093671 PECOS PAC ID: 7810974284 Enrollment ID: I20040706000094 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Adrienne B Dolinky |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1194783324 PECOS PAC ID: 4486631421 Enrollment ID: I20040707000630 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sherry L Norton |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1467444158 PECOS PAC ID: 9739167479 Enrollment ID: I20040709000885 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Chhatrapal S Thakur |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1871578088 PECOS PAC ID: 9739167800 Enrollment ID: I20040713001567 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Renee Lynn Novak |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1891806352 PECOS PAC ID: 5496735235 Enrollment ID: I20040722000864 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Naja Naddaf |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1255315875 PECOS PAC ID: 2567430127 Enrollment ID: I20040921001006 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Liem C Dang |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1942279963 PECOS PAC ID: 4183684327 Enrollment ID: I20041013000200 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Alvin Haynes |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1356438170 PECOS PAC ID: 4688635915 Enrollment ID: I20041020000980 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Hui Tang |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1649275488 PECOS PAC ID: 8921061847 Enrollment ID: I20041111000401 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Francelot Moise |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1528007721 PECOS PAC ID: 7719940527 Enrollment ID: I20041111000460 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Suzan E Zimmer |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1750351151 PECOS PAC ID: 8325002900 Enrollment ID: I20041113000160 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Ismael Rodriguez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1316938715 PECOS PAC ID: 1052376878 Enrollment ID: I20041122000312 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rose L Doyle |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1184644247 PECOS PAC ID: 4789642141 Enrollment ID: I20041231000039 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Frank D Fidler |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1508968488 PECOS PAC ID: 6507824968 Enrollment ID: I20041231000041 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Larry H Saunders |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1619077419 PECOS PAC ID: 2961456405 Enrollment ID: I20050308001039 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Aymen Atallah |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1417902339 PECOS PAC ID: 6305884776 Enrollment ID: I20050418000879 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Donita I Dobson |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1912086067 PECOS PAC ID: 1254371859 Enrollment ID: I20050503000872 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Eladio J Dieguez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1881631877 PECOS PAC ID: 5991746794 Enrollment ID: I20050520000796 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kavita A Thomas |
---|---|
Provider Type | Practitioner - Rheumatology |
Provider Identifiers | NPI Number: 1861423337 PECOS PAC ID: 3779514690 Enrollment ID: I20050830000592 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Hossam A Hessen |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1053445791 PECOS PAC ID: 8426073693 Enrollment ID: I20051007000190 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Robert P Kulchinsky |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1982683595 PECOS PAC ID: 0941228688 Enrollment ID: I20051110000647 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Husam E Eddin |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1629082607 PECOS PAC ID: 7113945874 Enrollment ID: I20051110000748 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Warren M Sturman |
---|---|
Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
Provider Identifiers | NPI Number: 1124094610 PECOS PAC ID: 5799708467 Enrollment ID: I20060109000496 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Igor Berengolts |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1588755367 PECOS PAC ID: 2961400783 Enrollment ID: I20061109000696 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Shahrzad J Grey |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1922066604 PECOS PAC ID: 9638066673 Enrollment ID: I20070420000066 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Abdul A Qazizada |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1124044672 PECOS PAC ID: 4688770985 Enrollment ID: I20070503000085 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Karla Jean Joviak |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1811083207 PECOS PAC ID: 2860599230 Enrollment ID: I20070518000336 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Hany B Mikhail |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1013014737 PECOS PAC ID: 7315046588 Enrollment ID: I20070628000559 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Poonam Warman |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1871508549 PECOS PAC ID: 7315030616 Enrollment ID: I20070831000448 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sheerin Patel |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1366542110 PECOS PAC ID: 7214021070 Enrollment ID: I20070924000624 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Juan C Yordan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1366410268 PECOS PAC ID: 8224097167 Enrollment ID: I20071015000218 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kenneth D Robertson |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1609070069 PECOS PAC ID: 5193811032 Enrollment ID: I20071023000562 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Giro Richard Samale |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1447258561 PECOS PAC ID: 9335032770 Enrollment ID: I20071101000626 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Vladimiro Giua |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1720045529 PECOS PAC ID: 5597854265 Enrollment ID: I20071203000567 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Syed W Hasan |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1952325029 PECOS PAC ID: 2961409693 Enrollment ID: I20080227000567 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lyza J Burgess |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1316122906 PECOS PAC ID: 5193894327 Enrollment ID: I20080514000488 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rafael Rondon |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1568667715 PECOS PAC ID: 3173694387 Enrollment ID: I20080616000605 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Elizabeth Wonpat |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1952503369 PECOS PAC ID: 5698875698 Enrollment ID: I20080819000195 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Nadia F Noor |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1821186685 PECOS PAC ID: 9032277033 Enrollment ID: I20081020000654 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Vorbes Aleger |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1790944700 PECOS PAC ID: 4284793498 Enrollment ID: I20081103000500 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Samira Khazravan |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1942494984 PECOS PAC ID: 9335218676 Enrollment ID: I20081114000554 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | William J Davila |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1346214277 PECOS PAC ID: 3173684685 Enrollment ID: I20081202000754 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Mohammad F Taj |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1720282106 PECOS PAC ID: 5890881486 Enrollment ID: I20090324000654 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Carolyn A Rawdon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1487893343 PECOS PAC ID: 8022167659 Enrollment ID: I20090601000236 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Patricia Cueto-lithgow |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1760611172 PECOS PAC ID: 1355497405 Enrollment ID: I20090915000649 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Francisco J Molina |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1295935120 PECOS PAC ID: 7911043005 Enrollment ID: I20091002000288 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Esther C Vildor-dazil |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1154454437 PECOS PAC ID: 9436295250 Enrollment ID: I20091008000574 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Alisha L Mcmorrow |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1548452758 PECOS PAC ID: 8426195926 Enrollment ID: I20091031000065 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rimal Patel |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1518195437 PECOS PAC ID: 6901944347 Enrollment ID: I20091105000251 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Fernando Diaz Mori |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1093972143 PECOS PAC ID: 8527134238 Enrollment ID: I20091222000571 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sidney E Clevinger |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1760461974 PECOS PAC ID: 9335281484 Enrollment ID: I20100127000735 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rachel Komala Moodey |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1124231774 PECOS PAC ID: 6800930785 Enrollment ID: I20100216000160 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Dwight Garfield Dawkins |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1164492005 PECOS PAC ID: 5991849507 Enrollment ID: I20100220000253 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Diane Leigh Pugh |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1073590667 PECOS PAC ID: 3476697855 Enrollment ID: I20100223000679 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Shriram S Marathe |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1134179922 PECOS PAC ID: 4183535487 Enrollment ID: I20100224000223 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Holly A West |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1790925436 PECOS PAC ID: 8820130743 Enrollment ID: I20100622000743 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sang H Chung |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1417968124 PECOS PAC ID: 9537293469 Enrollment ID: I20100814000088 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Swati Varshney |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1023147709 PECOS PAC ID: 4880710326 Enrollment ID: I20100922000308 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Bankim Patel |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1861699753 PECOS PAC ID: 7719078294 Enrollment ID: I20100923000381 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Gerson Rodriguez Baez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1912213133 PECOS PAC ID: 2264624832 Enrollment ID: I20101014000725 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Ewa D Piszczek |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1881708782 PECOS PAC ID: 9931105525 Enrollment ID: I20101026001514 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rickie Paul Sander |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1346200987 PECOS PAC ID: 5193858827 Enrollment ID: I20110214000118 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Margaret R Bell |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1588891618 PECOS PAC ID: 2163605437 Enrollment ID: I20110323000826 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rita M Wilson |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1528361532 PECOS PAC ID: 7810170735 Enrollment ID: I20110330000157 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Julie A Cronauer |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1871733642 PECOS PAC ID: 4082898663 Enrollment ID: I20110405001033 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kristin Kay Jones |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1396034278 PECOS PAC ID: 4789861121 Enrollment ID: I20110610000588 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Radharani S Gollamudi |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1245287713 PECOS PAC ID: 0547271652 Enrollment ID: I20110701000152 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Priya Rathan |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1689790487 PECOS PAC ID: 2264600477 Enrollment ID: I20110715000523 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Patricia Gilford |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1104090141 PECOS PAC ID: 1759424641 Enrollment ID: I20110808000833 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Daniel S Hutto |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1710274527 PECOS PAC ID: 6204008642 Enrollment ID: I20111007000407 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sean Shahla |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1801884119 PECOS PAC ID: 2062685977 Enrollment ID: I20111109000064 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Elizabeth S Collie-mickens |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1356578348 PECOS PAC ID: 7810163078 Enrollment ID: I20120110000594 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Ramon Guerrero Cueto |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1134301914 PECOS PAC ID: 2062595739 Enrollment ID: I20120118000783 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Melissa C Lozano |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1417227034 PECOS PAC ID: 9537328455 Enrollment ID: I20120313000834 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Terri-ann N Brown |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1437436433 PECOS PAC ID: 5092975227 Enrollment ID: I20120327000252 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jesse Balseiro |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1710203435 PECOS PAC ID: 2466616875 Enrollment ID: I20120615000225 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Marie Suzette Jeoboam |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1659491769 PECOS PAC ID: 1153586235 Enrollment ID: I20120625000163 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Robert S Barrett |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1538416680 PECOS PAC ID: 6002064813 Enrollment ID: I20120920000502 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Saigi Simon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1184975492 PECOS PAC ID: 9638329279 Enrollment ID: I20121017000423 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Joseph J Arena |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1245426279 PECOS PAC ID: 7517856313 Enrollment ID: I20121019000337 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Obaidullah Ahmed |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1235190646 PECOS PAC ID: 2264684596 Enrollment ID: I20121212000253 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Cathy C Vergara |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1548520596 PECOS PAC ID: 5496907727 Enrollment ID: I20121212000297 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Altia Aljeana Landis |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1457699324 PECOS PAC ID: 0143467498 Enrollment ID: I20130506000411 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kristi Lipps |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1275977761 PECOS PAC ID: 8123265824 Enrollment ID: I20130517000230 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Marcus A Frey |
---|---|
Provider Type | Practitioner - Podiatry |
Provider Identifiers | NPI Number: 1346521150 PECOS PAC ID: 6800033457 Enrollment ID: I20130520000178 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Fariba Zandieh |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1285978585 PECOS PAC ID: 6305084526 Enrollment ID: I20130530000159 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lillian Ingram |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1942564711 PECOS PAC ID: 1759520349 Enrollment ID: I20130611000518 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Glenna R Pick |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1962769398 PECOS PAC ID: 4981844347 Enrollment ID: I20130708000275 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Desiree B Touvoli |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1578816435 PECOS PAC ID: 9638310170 Enrollment ID: I20130726000238 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Philip B Paine |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1255642815 PECOS PAC ID: 8921249962 Enrollment ID: I20130802000251 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Grodonoff Nelson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1912213935 PECOS PAC ID: 4082856802 Enrollment ID: I20130807000685 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lori Jane Swanson |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1699116442 PECOS PAC ID: 2365686854 Enrollment ID: I20130924000393 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sirisha Talari |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1073777926 PECOS PAC ID: 1153580105 Enrollment ID: I20130930000114 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Derrick R Adams |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1902031735 PECOS PAC ID: 5193951705 Enrollment ID: I20131203001661 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Cynthia D Jacobs |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1578998019 PECOS PAC ID: 6002043619 Enrollment ID: I20131205000601 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Affiong Nsunwara |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1922310457 PECOS PAC ID: 9436386810 Enrollment ID: I20131210000471 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Janet M Mayo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1154751634 PECOS PAC ID: 9436387008 Enrollment ID: I20140107000221 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Melsah Riley-hazel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1316282494 PECOS PAC ID: 3779711577 Enrollment ID: I20140123001411 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Challis Grimm |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1659655074 PECOS PAC ID: 7810125614 Enrollment ID: I20140123001562 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Zainab J Qureshi |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1427340959 PECOS PAC ID: 6204078298 Enrollment ID: I20140305001458 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Cynthia A Westfield |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1598070187 PECOS PAC ID: 4082837158 Enrollment ID: I20140516001191 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Diane B Riggleman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336565753 PECOS PAC ID: 2961625454 Enrollment ID: I20140602002072 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Simone S Van-horne |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1225052103 PECOS PAC ID: 9830195205 Enrollment ID: I20140612002207 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Hesham Nasser |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1427345578 PECOS PAC ID: 0648495804 Enrollment ID: I20140701001274 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Stepan Y Kravchuk |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1124447214 PECOS PAC ID: 6901022748 Enrollment ID: I20140730002761 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Susan Armour |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1871660027 PECOS PAC ID: 0648497925 Enrollment ID: I20140811000150 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lori Austin |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1306252408 PECOS PAC ID: 8224947262 Enrollment ID: I20140912000589 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Tatyana V Solonskyi |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1063812709 PECOS PAC ID: 4880814813 Enrollment ID: I20140925001379 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Connie Horne |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1679853345 PECOS PAC ID: 4981824026 Enrollment ID: I20141013001256 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Angela I Donner |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1629496385 PECOS PAC ID: 0941421879 Enrollment ID: I20141017002074 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Heather Spencer |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1437565801 PECOS PAC ID: 2860614898 Enrollment ID: I20141106002107 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Leriche F Louis |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1477967834 PECOS PAC ID: 1456573195 Enrollment ID: I20141112001514 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Nana Mimura |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1568563625 PECOS PAC ID: 9537175658 Enrollment ID: I20141114001212 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rebecca L Mackowski |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1871996835 PECOS PAC ID: 8921320094 Enrollment ID: I20141126000740 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Laurette Que Cornel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1942691373 PECOS PAC ID: 4789900598 Enrollment ID: I20150312002380 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jennifer Pricher |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1710370499 PECOS PAC ID: 9133448467 Enrollment ID: I20150507001153 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Stephanie M Davis |
---|---|
Provider Type | Practitioner - Physician Assistant |
Provider Identifiers | NPI Number: 1649667833 PECOS PAC ID: 9335451137 Enrollment ID: I20150708001364 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Aamir Hussain |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1861729170 PECOS PAC ID: 0648429803 Enrollment ID: I20150721001569 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kimberly R Foncham Bradley |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1750773255 PECOS PAC ID: 2860705548 Enrollment ID: I20150723009451 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Maudeen C Scott |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1396149464 PECOS PAC ID: 0840503470 Enrollment ID: I20150724011603 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lissette Michelle Feliz |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1912342866 PECOS PAC ID: 7113231671 Enrollment ID: I20150729007182 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Abha Gupta |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1063745107 PECOS PAC ID: 2264603406 Enrollment ID: I20150817000859 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Justin Sager |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1730524133 PECOS PAC ID: 6608182381 Enrollment ID: I20150825005344 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Deena D Ganesh |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1194100842 PECOS PAC ID: 3971819319 Enrollment ID: I20150901000273 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Debbi R Croley |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1538544531 PECOS PAC ID: 5092022038 Enrollment ID: I20150923001899 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Otto Marquez Mendoza |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1679950695 PECOS PAC ID: 2062720055 Enrollment ID: I20150924000581 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Iszenn Joy H Nudalo-briganti |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1467828632 PECOS PAC ID: 1052620622 Enrollment ID: I20151021002485 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Stephanie M. Strobel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1063882223 PECOS PAC ID: 6103723226 Enrollment ID: I20151121000359 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Achyut N Gandhi |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1740288521 PECOS PAC ID: 8820068182 Enrollment ID: I20160218000805 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Robert Brus |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1699745943 PECOS PAC ID: 3678529211 Enrollment ID: I20160316002683 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Nakesha R Miller |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1497152540 PECOS PAC ID: 5496052813 Enrollment ID: I20160330002315 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sherry D Williams |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1164504734 PECOS PAC ID: 7012215171 Enrollment ID: I20160406001411 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jermaine A Campbell |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1407017387 PECOS PAC ID: 0840599551 Enrollment ID: I20160502001788 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Poonam Ishanpara |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1245629096 PECOS PAC ID: 8527385251 Enrollment ID: I20160516000831 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Susanna M Huhtamaki |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1255714093 PECOS PAC ID: 1153611850 Enrollment ID: I20160608002457 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Philippe Noel |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1346396801 PECOS PAC ID: 8325124613 Enrollment ID: I20160621000097 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Anna Berenstein |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1023047875 PECOS PAC ID: 3971636655 Enrollment ID: I20160621000237 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Alfonso E Martinez Irizarry |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1013192798 PECOS PAC ID: 5092884841 Enrollment ID: I20160627000275 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Virginia P Basnight |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1093169849 PECOS PAC ID: 1355632027 Enrollment ID: I20160628000984 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Brian S Pachmayer |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1073564555 PECOS PAC ID: 5395732804 Enrollment ID: I20160719001923 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Helen S Kirkendall |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1154779098 PECOS PAC ID: 5294028346 Enrollment ID: I20160727000238 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Angela Young |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1295196210 PECOS PAC ID: 5698062289 Enrollment ID: I20160926001450 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Radomir Piwko |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1033347166 PECOS PAC ID: 1052577335 Enrollment ID: I20161003002131 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Terra Jones |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1144778929 PECOS PAC ID: 8325326366 Enrollment ID: I20161026002407 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Axel E Martinez Irizarry |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1689860421 PECOS PAC ID: 6103971353 Enrollment ID: I20161103002134 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sudeep Singh |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1104173210 PECOS PAC ID: 8123322237 Enrollment ID: I20161114002416 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Abduljabbar Al Tekreeti |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1043503436 PECOS PAC ID: 5799064796 Enrollment ID: I20161115001934 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sergio Hernandez Borges |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1043600414 PECOS PAC ID: 7012203458 Enrollment ID: I20161119000046 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Dennis T Besong |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1639514532 PECOS PAC ID: 5395984363 Enrollment ID: I20161130001796 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Yong Mei Ni |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1073796637 PECOS PAC ID: 6800921354 Enrollment ID: I20161209000929 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Nikki Little |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1457801623 PECOS PAC ID: 4183903800 Enrollment ID: I20161227001564 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Siji A Jose |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1972045235 PECOS PAC ID: 5294016580 Enrollment ID: I20161228000863 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sean B Stephens |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1588112700 PECOS PAC ID: 1951682004 Enrollment ID: I20170103001105 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rafat Ahmed |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1255889556 PECOS PAC ID: 2365723319 Enrollment ID: I20170105000615 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Bryant W Wilson |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1639501265 PECOS PAC ID: 1850670050 Enrollment ID: I20170120002171 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Christopher Wayne Dion |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1912457029 PECOS PAC ID: 0840572905 Enrollment ID: I20170125000913 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Donoffa E Nelson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1487027637 PECOS PAC ID: 6305128380 Enrollment ID: I20170127000232 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Vijaya Siddalingappa |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1558595884 PECOS PAC ID: 9234411034 Enrollment ID: I20170130002714 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Holly A Mulvey |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1639534159 PECOS PAC ID: 8123304565 Enrollment ID: I20170419000781 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Rita M Malpedo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336674043 PECOS PAC ID: 8820365596 Enrollment ID: I20170531000445 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jean Bertrand Merozier |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1427400720 PECOS PAC ID: 6103193651 Enrollment ID: I20170605000726 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Myrna Go |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1568997609 PECOS PAC ID: 1254609464 Enrollment ID: I20170612002586 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Yaazmiyn S White |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1881130060 PECOS PAC ID: 7012285562 Enrollment ID: I20170626000180 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Taiche D Griffin |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1124552112 PECOS PAC ID: 8628347200 Enrollment ID: I20170713002087 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Skeeter A Thompson Nembhard |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1861859183 PECOS PAC ID: 9335436971 Enrollment ID: I20170719001746 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sajeena Mathai |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1013453166 PECOS PAC ID: 8426329095 Enrollment ID: I20170801002080 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Tameca E Bakker |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1942615612 PECOS PAC ID: 1254559461 Enrollment ID: I20170807002686 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Christopher L Hill |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1366434896 PECOS PAC ID: 8022082759 Enrollment ID: I20170825001006 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Leah A Majarocon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1164706610 PECOS PAC ID: 0042471567 Enrollment ID: I20170829002727 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jeannan Haygood |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1982024006 PECOS PAC ID: 6901170893 Enrollment ID: I20170915000657 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Sara R Schiffman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1225571714 PECOS PAC ID: 7416222575 Enrollment ID: I20170929001093 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Erick Gonzalez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1265827158 PECOS PAC ID: 6204101041 Enrollment ID: I20171004003374 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Julia A Monahan |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1487814414 PECOS PAC ID: 5092880468 Enrollment ID: I20171024000599 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Steven Ventrudo |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1265432736 PECOS PAC ID: 4789721515 Enrollment ID: I20171025001348 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Laura Partlow |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1326561945 PECOS PAC ID: 2264798073 Enrollment ID: I20171110002727 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Nadezhda Gonzalez |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1568874667 PECOS PAC ID: 6800194135 Enrollment ID: I20171113000421 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Edward Orshansky |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1285054460 PECOS PAC ID: 8820218548 Enrollment ID: I20171120003394 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Unyime J Usoro |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1730698226 PECOS PAC ID: 8224396437 Enrollment ID: I20171218000503 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jametria Qwanice Howard-jones |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1487064317 PECOS PAC ID: 7810256435 Enrollment ID: I20180104001968 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Mareena C Hanna |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1841674546 PECOS PAC ID: 4587923933 Enrollment ID: I20180123001663 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jocelin Joseph |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1154797470 PECOS PAC ID: 3577824937 Enrollment ID: I20180227001155 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Mary C Kawalya |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1497256861 PECOS PAC ID: 6002177094 Enrollment ID: I20180308001674 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kimberly H Clayton |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1447759543 PECOS PAC ID: 1850654195 Enrollment ID: I20180418002752 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Raja Sadiq |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1255488896 PECOS PAC ID: 9133270127 Enrollment ID: I20180503000787 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Felecia Maria Sanchious |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1326548686 PECOS PAC ID: 7113281338 Enrollment ID: I20180515002801 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Joseph N Robbins |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1679951321 PECOS PAC ID: 1355657669 Enrollment ID: I20190131002821 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Mohammed M Basha |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1043312150 PECOS PAC ID: 0244400448 Enrollment ID: I20190207001158 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Gary M Clay |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1548705239 PECOS PAC ID: 4981977360 Enrollment ID: I20190214001216 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Victoria Cook |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1255484788 PECOS PAC ID: 2860455995 Enrollment ID: I20190222001434 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Niti Aggarwal |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1457745499 PECOS PAC ID: 0840507182 Enrollment ID: I20190226000120 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Glodene S Roberts |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1689160913 PECOS PAC ID: 1456690924 Enrollment ID: I20190227001413 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Raja Naveed I Sadiq |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1821064213 PECOS PAC ID: 6103712443 Enrollment ID: I20190327001678 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Katelyn Sloan Peworchik |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1912489519 PECOS PAC ID: 2860726056 Enrollment ID: I20190621000713 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Louella C Marinos |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1689230591 PECOS PAC ID: 7618202565 Enrollment ID: I20190715001347 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Adam C Major |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1669970133 PECOS PAC ID: 8921336967 Enrollment ID: I20190828003042 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Gaston Metelus |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1235638602 PECOS PAC ID: 3274862172 Enrollment ID: I20190830002238 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Stephanie R Barclay |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1134772668 PECOS PAC ID: 3173852100 Enrollment ID: I20190917000439 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Aline Paredes |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1447815907 PECOS PAC ID: 0941531040 Enrollment ID: I20191003001639 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jill M Huntzinger |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336686534 PECOS PAC ID: 8729357108 Enrollment ID: I20191010002628 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Kaushambi A Parghi |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1972989523 PECOS PAC ID: 3971892118 Enrollment ID: I20191017002712 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Olena Georgiyeva |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1093257784 PECOS PAC ID: 8820372410 Enrollment ID: I20191023001200 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lolanda Francis-blackshear |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336795319 PECOS PAC ID: 4183059249 Enrollment ID: I20200117000633 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Laura Casey |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1790230183 PECOS PAC ID: 9032497029 Enrollment ID: I20200218001583 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Beth E Brown |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1346327657 PECOS PAC ID: 6204263734 Enrollment ID: I20200225000754 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | James Walter Lofton |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1386275840 PECOS PAC ID: 2264863315 Enrollment ID: I20200506000491 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Cheryl Y King |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1801242318 PECOS PAC ID: 4587953229 Enrollment ID: I20200716000785 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Jimmy Dourado |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1770014714 PECOS PAC ID: 2860765252 Enrollment ID: I20200717001653 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Trevon Jarrod Friar |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1689291726 PECOS PAC ID: 8921423971 Enrollment ID: I20200807000429 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Yesika Alejandra Garcia Lopez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1104277219 PECOS PAC ID: 4587903257 Enrollment ID: I20200814001158 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Susan Wakesho Ngondo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1962088047 PECOS PAC ID: 4789092321 Enrollment ID: I20210420000407 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Wilta Soirelus |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1447846357 PECOS PAC ID: 4486054996 Enrollment ID: I20210621000568 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Amer Zeizoun |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1831652882 PECOS PAC ID: 2365846011 Enrollment ID: I20210803002764 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Anne Ritchie Ritchie Moise |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1477145746 PECOS PAC ID: 8729470901 Enrollment ID: I20220120000881 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Lisa Leclair |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1104399880 PECOS PAC ID: 1557604493 Enrollment ID: I20220210001549 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Angela Lindsay |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1194131714 PECOS PAC ID: 8820219728 Enrollment ID: I20220304001274 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Djephlie Calixte Pierre |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1972167716 PECOS PAC ID: 8628457884 Enrollment ID: I20220617000445 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Diego Ulises Cruz |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1255076261 PECOS PAC ID: 5092194829 Enrollment ID: I20220623003413 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Stephen Michael May |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1457082737 PECOS PAC ID: 3577944115 Enrollment ID: I20220714000032 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | David Jones |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1316949662 PECOS PAC ID: 5799723318 Enrollment ID: I20220722001903 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Stephanie Jones |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1033850417 PECOS PAC ID: 0840674180 Enrollment ID: I20220906000354 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Mustafa A Alsaid Alkhreisat |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1205268588 PECOS PAC ID: 3678869153 Enrollment ID: I20221229000577 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Asmita Marwah |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1487901781 PECOS PAC ID: 1153635297 Enrollment ID: I20230324002474 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Bridgenett James-barrie |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1134529746 PECOS PAC ID: 4082070313 Enrollment ID: I20230511002494 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Carissa M Kelly |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1821307646 PECOS PAC ID: 2264627132 Enrollment ID: I20230518002183 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Benita Lane |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1174774756 PECOS PAC ID: 0446482004 Enrollment ID: I20230828003469 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Paveena Posang |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1225000953 PECOS PAC ID: 1557464500 Enrollment ID: I20231114000355 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Provider Name | Nadia Marie Oquendo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1275176547 PECOS PAC ID: 6709211790 Enrollment ID: I20240201000528 |
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
News Archive
Many young women do not want to start taking the contraceptive pill because they are worried that they will put on weight, or come off it because they think that they have gained weight because of it. However, a thesis from the University of Gothenburg, Sweden, has demonstrated that the combined contraceptive pill does not cause weight increase.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment.
› Verified 5 days ago
Avalon Behavior Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1190 E Washington St, Ph29, Tampa, FL 33602 Phone: 510-313-8290 | |
Varghese Kodiyan Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 602 Shellcracker Ct, Tampa, FL 33613 Phone: 813-245-7326 | |
Tampa Life Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 13035 W. Linebaugh Ave #101 Ste G, Tampa, FL 33626 Phone: 813-906-8852 | |
Embracing Changes Center For Wellness Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4830 W Kennedy Blvd Ste 630, Tampa, FL 33609 Phone: 813-486-4920 Fax: 813-428-5756 | |
Vip Senior Wellness Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 10115 Vista Pointe Dr, Tampa, FL 33635 Phone: 718-942-6595 | |
Crudup Psychological Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10001 Cross Creek Blvd, Tampa, FL 33647 Phone: 386-243-9220 | |
Grow, Empower, Transform Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13542 N Florida Ave Ste 210, Tampa, FL 33613 Phone: 813-563-8227 |